Coronary arterial 18F-FDG uptake by fusion of PET and coronary CT angiography at sites of percutaneous stenting for acute myocardial infarction and stable coronary artery disease

Journal of Nuclear Medicine

Volumn 53, Issue 4, 2012, Pages 575-583

  Cheng, Victor Y ^a,b   Slomka, Piotr J ^a,b   Le Meunier, Ludovic ^a   Tamarappoo, Balaji K ^c   Nakazato, Ryo ^a   Dey, Damini ^a,b   Berman, Daniel S ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Computed tomography; Coronary artery; Fluorodeoxyglucose; Inflammation; Positron emission tomograph

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARBOHYDRATE DIET; CARDIOVASCULAR INFLAMMATION; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DOSE RESPONSE; DRUG UPTAKE; FEMALE; HUMAN; IMAGE ANALYSIS; IN VIVO STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE STUDY; RADIATION DOSE; SIGNAL DETECTION; SMOKING; ACUTE DISEASE; CLINICAL TRIAL; CORONARY BLOOD VESSEL; HEART INFARCTION; IMAGE PROCESSING; METABOLISM; MIDDLE AGED; SCINTISCANNING; SKIN; STENT; TRANSPORT AT THE CELLULAR LEVEL;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BIOLOGICAL TRANSPORT; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POSITRON-EMISSION TOMOGRAPHY; SKIN; STENTS;

EID: 84859406041     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.097550     Document Type: Article

References (29)

1. Boyle JJ. Association of coronary plaque rupture and atherosclerotic inflammation. J Pathol. 1997;181:93-99. (Pubitemid 27099780)
2. Pasterkamp G, Schoneveld AH, van der Wal AC, et al. Inflammation of the atherosclerotic cap and shoulder of the plaque is a common and locally observed feature in unruptured plaques of femoral and coronary arteries. Arterioscler Thromb Vasc Biol. 1999;19:54-58. (Pubitemid 29031912)
3. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44. (Pubitemid 24026469)
4. Blockmans D, Maes A, Stroobants S, et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford). 1999;38:444-447. (Pubitemid 29507129)
5. 18F-FDG PET/CT and histology. J Nucl Med. 2009;50:959-965.
6. Tawakol A, Migrino RQ, Hoffmann U, et al. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol. 2005;12:294-301. (Pubitemid 40790404)
7. 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke. 2005;36: 2642-2647.
8. 18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105:2708-2711.
9. 18F- fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol. 2006;48:1818-1824.
10. Alexanderson E, Slomka P, Cheng V, et al. Fusion of positron emission tomography and coronary computed tomographic angiography identifies fluorine 18 fluorodeoxyglucose uptake in the left main coronary artery soft plaque. J Nucl Cardiol. 2008;15:841-843.
11. 18F-FDG uptake with vascular calcification. J Nucl Med. 2005;46:1278-1284.
12. Rogers IS, Nasir K, Figueroa AL, et al. Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. JACC Cardiovasc Imaging. 2010;3:388-397.
13. 18F-FDG uptake during PET: a randomized controlled trial. J Nucl Cardiol. 2010;17:286-291.
14. Frolov VA, Demurov EA, Efimova LV, Kazanskaia TA, Pukhlianko VP. Effect of large heparin doses on the contractile function, structure and lipid metabolic indices of the myocardium in intact rabbits [in Russian]. Kardiologiia. 1980;20:92-95. (Pubitemid 10060647)
15. Thomassen A, Nielsen TT, Bagger JP, Henningsen P. Cardiac metabolic effects of heparin differentiate between patients with normal and stenotic coronary arteries. Int J Cardiol. 1990;27:37-46. (Pubitemid 20097467)
16. Le Meunier L, Slomka PJ, Dey D, et al. Enhanced definition PET for cardiac imaging. J Nucl Cardiol. 2010;17:414-426.
17. Panin VY, Kehren F, Michel C, Casey M. Fully 3-D PET reconstruction with system matrix derived from point source measurements. IEEE Trans Med Imaging. 2006;25:907-921. (Pubitemid 44088375)
18. Hausleiter J, Meyer T, Hermann F, et al. Estimated radiation dose associated with cardiac CT angiography. JAMA. 2009;301:500-507.
19. McCollough CH, Christner JA, Kofler JM. How effective is effective dose as a predictor of radiation risk? AJR. 2010;194:890-896.
20. Einstein AJ, Moser KW, Thompson RC, Cerqueira MD, Henzlova MJ. Radiation dose to patients from cardiac diagnostic imaging. Circulation. 2007;116:1290-1305. (Pubitemid 47517541)
21. 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. J Nucl Med. 2009;50:563-568.
22. Mao S, Lu B, Oudiz RJ, Bakhsheshi H, Liu SC, Budoff MJ. Coronary artery motion in electron beam tomography. J Comput Assist Tomogr. 2000;24:253-258. (Pubitemid 32206203)
23. Slomka PJ, Le Meunier L, Hayes SW, et al. Comparison of myocardial perfusion 82Rb PET performed with CT- and transmission CT-based attenuation correction. J Nucl Med. 2008;49:1992-1998.
24. 18F]2-fluoro-2-deoxy-d- glucose: a new absolute threshold technique. Eur J Nucl Med Mol Imaging. 2002;29:203-215.
25. Lautamäki R, Schuleri KH, Sasano T, et al. Integration of infarct size, tissue perfusion, and metabolism by hybrid cardiac positron emission tomography/computed tomography: evaluation in a porcine model of myocardial infarction. Circ Cardiovasc Imaging. 2009;2:299-305.
26. Harisankar CN, Mittal BR, Agrawal KL, Abrar ML, Bhattacharya A. Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake. J Nucl Cardiol. 2011;18:926-936.
27. 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. AJR. 2008;190:W151-6.
28. Ishii H, Nishio M, Takahashi H, et al. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigatorblinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention. Clin Ther. 2010;32:2337-2347.
29. Tahara N, Kai H, Ishibashi M, et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2006;48:1825-1831. (Pubitemid 44648621)